Feedback / Questions
inobrodib (CCS1477) - CellCentric
https://www.newsfilecorp.com/release/265626/CellCentric-Announces-Completion-of-Enrollment-for-Dose-Optimization-Cohorts-in-Phase-2-Study-for-Multiple-Myeloma
Sep 9, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next